Document is current
Any future updates will be listed below
-
Authors
Duval, Xavier
Collin, Cédric
Baloche, Alexiane
Fanchon, Laurent
Nora, Tamara
Hoen, Bruno
- License Information
-
More Information
Article History
Received: 15 April 2025
Accepted: 13 October 2025
First Online: 10 November 2025
Declarations
:
: Our study protocol was reviewed and approved by the Comité Éthique et Scientifique pour les Recherches , les Études et les Évaluations dans le domaine de la Santé (CESREES) on 8 October 2020 (No. TPS2483887) and by the Commission Nationale de l’Informatique et des Libertés (CNIL) on 1 February 2021 (CNIL, MLD/VCS/AR212214, No. 920458). Informed consent was waived by the Commission Nationale de l’Informatique et des Libertés (CNIL in French) as this study was retrospective on a pseudo-anonymised database and did not influence care. This study was conducted according to national laws, regulations, and the declaration of Helsinki.
: Not applicable.
: BH and XD declare that they have no competing interests except consulting fees for this study.CC is employed by IQVIA which received funding from Sanofi to run the study.TN, AB and LF are Sanofi employees and may hold shares in the company.
